LENZ Therapeutics, Inc.
LENZ • NASDAQ • Stock Fundamentals
LENZ Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Evert Schimmelpennink, with a market cap of $243.0M.
Market Cap$243.0M
CEOEvert Schimmelpennink
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsJul 29, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
LENZ Therapeutics, Inc. FAQ
Common questions about LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. (LENZ) has a market capitalization of $243.0M and trades on NASDAQ.